Spotlight on Japan: A supportive government but market share declines

Published on December 19, 2024

In a series exploring trends across the APAC region, Norstella’s subject matter experts from key biopharma hubs delve into this year’s standout developments and share their outlook for 2025. Andrew Warmington, Manufacturing Editor at Citeline, spoke to Ian Haydock, Editor-In-Chief, and Lisa Takagi, Managing Editor at Insights in the APAC region, about key developments this […]

Continue reading on website
Other news

BioPharm International: Optimizing Process Development for Biologics

December 18, 2024
BioPharm International’s latest issue features an interview with Abzena’s Vice President of Biologics Development, Dr Daniel Giroux, discussing insights into optimizing process development strategies for biologics.The development and production of biologics can be a complex process. And the manufacture of biopharmaceuticals requires that processes be developed and validated so that product specifi

MHC-Associated Peptide Proteomics: Immunogenicity and Vaccine Design

January 2, 2025
Authors:Dr Campbell Bunce, Chief Scientific OfficerEdward Cloake, Director of ImmunologyImmunogenicity assessment is essential in any therapeutic protein development. But there’s a key step in this process that’s both powerful and versatile: major histocompatibility complex (MHC)-associated peptide proteomics (MAPPs), a complex yet informative assay that gives detailed insights into the immunogeni